An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa

Trial Profile

An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa

Completed
Phase of Trial: Phase I/II

Latest Information Update: 05 Apr 2014

At a glance

  • Drugs Brimonidine (Primary)
  • Indications Retinitis pigmentosa
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Apr 2014 New trial record
    • 09 Sep 2010
    • 27 Aug 2009
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top